$DNLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Denali Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Denali Therapeutics Inc.. Get notifications about new insider transactions in Denali Therapeutics Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 63.76 | 6,222 | 396,715 | 6,222 | |
Jun 04 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Grant | A | 0.00 | 2,074 | 0 | 2,544,370 | 2.5 M to 2.5 M (+0.08 %) |
Jun 04 2021 | DNLI | Denali Therapeutic ... | FLATLEY JAY T | Director | Option Exercise | A | 63.76 | 6,222 | 396,715 | 6,222 | |
Jun 04 2021 | DNLI | Denali Therapeutic ... | FLATLEY JAY T | Director | Grant | A | 0.00 | 2,074 | 0 | 330,327 | 328.3 K to 330.3 K (+0.63 %) |
Jun 04 2021 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 63.76 | 6,222 | 396,715 | 6,222 | |
Jun 04 2021 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Grant | A | 0.00 | 2,074 | 0 | 5,327 | 3.3 K to 5.3 K (+63.76 %) |
Jun 03 2021 | DNLI | Denali Therapeutic ... | Klein Peter S | Director | Option Exercise | M | 0.00 | 3,253 | 0 | 0 | |
Jun 03 2021 | DNLI | Denali Therapeutic ... | Klein Peter S | Director | Option Exercise | M | 0.00 | 3,253 | 0 | 0 | |
Jun 03 2021 | DNLI | Denali Therapeutic ... | Klein Peter S | Director | Buy | M | 0.00 | 3,253 | 0 | 3,253 | 0 to 3.3 K |
Jun 03 2021 | DNLI | Denali Therapeutic ... | Klein Peter S | Director | Buy | M | 0.00 | 3,253 | 0 | 3,253 | 0 to 3.3 K |
May 24 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 60.03 | 8,806 | 528,580 | 2,542,296 | 2.6 M to 2.5 M (-0.35 %) |
May 24 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 60.13 | 37,957 | 2,282,468 | 2,551,102 | 2.6 M to 2.6 M (-1.47 %) |
May 06 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 57.39 | 445 | 25,539 | 511,582 | 512 K to 511.6 K (-0.09 %) |
May 06 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 55.92 | 3,557 | 198,890 | 512,027 | 515.6 K to 512 K (-0.69 %) |
May 06 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 55.09 | 5,998 | 330,436 | 515,584 | 521.6 K to 515.6 K (-1.15 %) |
May 05 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 59.92 | 851 | 50,989 | 2,229,075 | 2.2 M to 2.2 M (-0.04 %) |
May 05 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 59.12 | 3,485 | 206,030 | 2,229,926 | 2.2 M to 2.2 M (-0.16 %) |
May 05 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 58.45 | 13,997 | 818,083 | 2,233,411 | 2.2 M to 2.2 M (-0.62 %) |
Apr 30 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 63.03 | 688 | 43,367 | 135,755 | 136.4 K to 135.8 K (-0.50 %) |
Apr 30 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 62.05 | 597 | 37,042 | 136,443 | 137 K to 136.4 K (-0.44 %) |
Apr 30 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 60.71 | 381 | 23,129 | 137,040 | 137.4 K to 137 K (-0.28 %) |
Apr 06 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 57.44 | 700 | 40,206 | 521,582 | 522.3 K to 521.6 K (-0.13 %) |
Apr 06 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 56.47 | 4,156 | 234,669 | 522,282 | 526.4 K to 522.3 K (-0.79 %) |
Apr 06 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 55.60 | 5,144 | 286,027 | 526,438 | 531.6 K to 526.4 K (-0.97 %) |
Apr 05 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 57.31 | 4,586 | 262,842 | 2,247,408 | 2.3 M to 2.2 M (-0.20 %) |
Apr 05 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 56.88 | 8,516 | 484,356 | 2,251,994 | 2.3 M to 2.3 M (-0.38 %) |
Apr 05 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 55.52 | 5,232 | 290,486 | 2,260,510 | 2.3 M to 2.3 M (-0.23 %) |
Apr 05 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Gift | G | 0.00 | 40,000 | 0 | 2,265,742 | 2.3 M to 2.3 M (-1.73 %) |
Apr 01 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 57.61 | 136 | 7,834 | 137,421 | 137.6 K to 137.4 K (-0.10 %) |
Apr 01 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 56.92 | 635 | 36,145 | 137,557 | 138.2 K to 137.6 K (-0.46 %) |
Apr 01 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 57.61 | 136 | 7,834 | 137,421 | 137.6 K to 137.4 K (-0.10 %) |
Apr 01 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 55.91 | 877 | 49,034 | 138,192 | 139.1 K to 138.2 K (-0.63 %) |
Apr 01 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 56.92 | 635 | 36,145 | 137,557 | 138.2 K to 137.6 K (-0.46 %) |
Apr 01 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 54.38 | 18 | 979 | 139,069 | 139.1 K to 139.1 K (-0.01 %) |
Apr 01 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 55.91 | 877 | 49,034 | 138,192 | 139.1 K to 138.2 K (-0.63 %) |
Apr 01 2021 | DNLI | Denali Therapeutic ... | SATO VICKI L | Director | Sell | S | 54.38 | 18 | 979 | 139,069 | 139.1 K to 139.1 K (-0.01 %) |
Mar 31 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 54.62 | 2,822 | 154,126 | 162,319 | 165.1 K to 162.3 K (-1.71 %) |
Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 63.67 | 1,158 | 73,730 | 850,000 | 851.2 K to 850 K (-0.14 %) |
Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 62.71 | 3,258 | 204,319 | 851,158 | 854.4 K to 851.2 K (-0.38 %) |
Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 62.04 | 32,326 | 2,005,602 | 854,416 | 886.7 K to 854.4 K (-3.65 %) |
Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 61.16 | 13,258 | 810,912 | 886,742 | 900 K to 886.7 K (-1.47 %) |
Mar 04 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 61.58 | 1,878 | 115,647 | 531,582 | 533.5 K to 531.6 K (-0.35 %) |
Mar 04 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 60.89 | 8,122 | 494,524 | 533,460 | 541.6 K to 533.5 K (-1.50 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 71.27 | 68 | 4,846 | 165,141 | 165.2 K to 165.1 K (-0.04 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 70.07 | 125 | 8,758 | 165,209 | 165.3 K to 165.2 K (-0.08 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 68.87 | 208 | 14,324 | 165,334 | 165.5 K to 165.3 K (-0.13 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 68.01 | 1,320 | 89,772 | 165,542 | 166.9 K to 165.5 K (-0.79 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 67.07 | 1,173 | 78,670 | 166,862 | 168 K to 166.9 K (-0.70 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 65.74 | 2,871 | 188,725 | 168,035 | 170.9 K to 168 K (-1.68 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 64.54 | 1,327 | 85,646 | 170,906 | 172.2 K to 170.9 K (-0.77 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 71.35 | 1,031 | 73,563 | 2,642,296 | 2.6 M to 2.6 M (-0.04 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 69.59 | 3,482 | 242,309 | 2,643,327 | 2.6 M to 2.6 M (-0.13 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 68.50 | 6,011 | 411,778 | 2,646,809 | 2.7 M to 2.6 M (-0.23 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 67.57 | 14,945 | 1,009,834 | 2,652,820 | 2.7 M to 2.7 M (-0.56 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 66.55 | 18,316 | 1,219,003 | 2,667,765 | 2.7 M to 2.7 M (-0.68 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 65.63 | 37,445 | 2,457,665 | 2,686,081 | 2.7 M to 2.7 M (-1.37 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 64.36 | 18,770 | 1,208,056 | 2,723,526 | 2.7 M to 2.7 M (-0.68 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 70.92 | 68 | 4,823 | 2,305,742 | 2.3 M to 2.3 M (0.00 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 69.65 | 594 | 41,371 | 2,305,810 | 2.3 M to 2.3 M (-0.03 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 68.46 | 1,625 | 111,246 | 2,306,404 | 2.3 M to 2.3 M (-0.07 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 67.69 | 3,339 | 226,017 | 2,308,029 | 2.3 M to 2.3 M (-0.14 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 66.55 | 3,453 | 229,780 | 2,311,368 | 2.3 M to 2.3 M (-0.15 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 65.63 | 5,885 | 386,209 | 2,314,821 | 2.3 M to 2.3 M (-0.25 %) |
Mar 03 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 64.42 | 3,370 | 217,106 | 2,320,706 | 2.3 M to 2.3 M (-0.15 %) |
Feb 17 2021 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 65.00 | 2,216,798 | 144,091,870 | 9,984,836 | 12.2 M to 10 M (-18.17 %) |
Feb 16 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 71.49 | 400 | 28,594 | 172,233 | 172.6 K to 172.2 K (-0.23 %) |
Feb 16 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 70.17 | 2,756 | 193,377 | 172,633 | 175.4 K to 172.6 K (-1.57 %) |
Feb 16 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 71.41 | 433 | 30,920 | 541,582 | 542 K to 541.6 K (-0.08 %) |
Feb 16 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 70.17 | 2,614 | 183,422 | 542,015 | 544.6 K to 542 K (-0.48 %) |
Feb 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 71.43 | 400 | 28,571 | 97,587 | 98 K to 97.6 K (-0.41 %) |
Feb 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 70.17 | 2,635 | 184,908 | 97,987 | 100.6 K to 98 K (-2.62 %) |
Feb 16 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 71.47 | 960 | 68,610 | 2,324,076 | 2.3 M to 2.3 M (-0.04 %) |
Feb 16 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 70.17 | 8,513 | 597,374 | 2,325,036 | 2.3 M to 2.3 M (-0.36 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | M | 0.00 | 4,250 | 0 | 8,500 | |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 75.68 | 206 | 15,591 | 537,344 | 537.6 K to 537.3 K (-0.04 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Sell | S | 74.66 | 1,262 | 94,218 | 537,550 | 538.8 K to 537.6 K (-0.23 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Buy | M | 0.00 | 4,250 | 0 | 538,812 | 534.6 K to 538.8 K (+0.80 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 4,250 | 0 | 8,500 | |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 75.39 | 426 | 32,116 | 12,979 | 13.4 K to 13 K (-3.18 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 74.38 | 1,022 | 76,018 | 13,405 | 14.4 K to 13.4 K (-7.08 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | M | 0.00 | 4,250 | 0 | 14,427 | 10.2 K to 14.4 K (+41.76 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 0.00 | 4,250 | 0 | 8,500 | |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 76.00 | 100 | 7,600 | 167,921 | 168 K to 167.9 K (-0.06 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 75.10 | 364 | 27,337 | 168,021 | 168.4 K to 168 K (-0.22 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 74.40 | 1,006 | 74,847 | 168,385 | 169.4 K to 168.4 K (-0.59 %) |
Feb 11 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 0.00 | 4,250 | 0 | 169,391 | 165.1 K to 169.4 K (+2.57 %) |
Feb 10 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Option Exercise | M | 0.00 | 8,800 | 0 | 17,600 | |
Feb 10 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Option Exercise | M | 0.00 | 5,516 | 0 | 0 | |
Feb 10 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 75.07 | 811 | 60,883 | 2,313,853 | 2.3 M to 2.3 M (-0.04 %) |
Feb 10 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 74.05 | 1,634 | 120,999 | 2,314,664 | 2.3 M to 2.3 M (-0.07 %) |
Feb 10 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 73.24 | 2,667 | 195,328 | 2,316,298 | 2.3 M to 2.3 M (-0.12 %) |
Feb 10 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Buy | M | 0.00 | 8,800 | 0 | 2,318,965 | 2.3 M to 2.3 M (+0.38 %) |
Feb 10 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Buy | M | 0.00 | 5,516 | 0 | 2,310,165 | 2.3 M to 2.3 M (+0.24 %) |
Feb 02 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 69.69 | 560 | 39,026 | 2,304,649 | 2.3 M to 2.3 M (-0.02 %) |
Feb 02 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 69.17 | 3,552 | 245,681 | 2,305,209 | 2.3 M to 2.3 M (-0.15 %) |
Feb 02 2021 | DNLI | Denali Therapeutic ... | Watts Ryan J. | President and CEO | Sell | S | 68.21 | 14,222 | 970,111 | 2,308,761 | 2.3 M to 2.3 M (-0.61 %) |
Jan 20 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 73.01 | 14,147 | 1,032,816 | 950,000 | 964.1 K to 950 K (-1.47 %) |
Jan 20 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 71.99 | 8,071 | 581,047 | 964,147 | 972.2 K to 964.1 K (-0.83 %) |
Jan 20 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 70.96 | 12,981 | 921,158 | 972,218 | 985.2 K to 972.2 K (-1.32 %) |
Jan 20 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 70.10 | 14,801 | 1,037,535 | 985,199 | 1000 K to 985.2 K (-1.48 %) |
Jan 12 2021 | DNLI | Denali Therapeutic ... | Thornberry Nancy | Director | Option Exercise | A | 0.00 | 2,511 | 0 | 2,511 | |
Jan 12 2021 | DNLI | Denali Therapeutic ... | Thornberry Nancy | Director | Option Exercise | A | 80.03 | 7,535 | 603,026 | 7,535 | |
Jan 06 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 70.86 | 90,000 | 6,377,400 | 90,000 | |
Jan 06 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Jan 06 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | A | 70.86 | 90,000 | 6,377,400 | 90,000 | |
Jan 06 2021 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Dec 23 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | J | 0.00 | 383,411 | 0 | 0 | 383.4 K to 0 (-100.00 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 90.01 | 5,000 | 450,027 | 26,232 | 31.2 K to 26.2 K (-16.01 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 90.06 | 25,000 | 2,251,555 | 0 | 25 K to 0 (-100.00 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 90.01 | 5,000 | 450,027 | 26,232 | 31.2 K to 26.2 K (-16.01 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 90.06 | 25,000 | 2,251,555 | 0 | 25 K to 0 (-100.00 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 81.13 | 876 | 71,068 | 383,411 | 384.3 K to 383.4 K (-0.23 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 80.35 | 16,949 | 1,361,774 | 384,287 | 401.2 K to 384.3 K (-4.22 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 80.05 | 46,799 | 3,746,442 | 401,236 | 448 K to 401.2 K (-10.45 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 81.13 | 876 | 71,068 | 383,411 | 384.3 K to 383.4 K (-0.23 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 80.35 | 16,949 | 1,361,774 | 384,287 | 401.2 K to 384.3 K (-4.22 %) |
Dec 15 2020 | DNLI | Denali Therapeutic ... | BRATTON DOUGLAS K | 10% Owner | Sell | S | 80.05 | 46,799 | 3,746,442 | 401,236 | 448 K to 401.2 K (-10.45 %) |
Nov 13 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 70.05 | 30,000 | 2,101,590 | 25,000 | 55 K to 25 K (-54.55 %) |
Nov 12 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 60.03 | 10,000 | 600,310 | 55,000 | 65 K to 55 K (-15.38 %) |
Nov 06 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 50.18 | 10,000 | 501,830 | 65,000 | 75 K to 65 K (-13.33 %) |
Oct 13 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 30,000 | 158,400 | 38,240 | |
Oct 13 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 9,886 | 52,198 | 68,240 | |
Oct 13 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 5.28 | 13,020 | 68,746 | 44,035 | |
Oct 13 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 41.51 | 19,535 | 810,898 | 166,617 | 186.2 K to 166.6 K (-10.49 %) |
Oct 13 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 40.68 | 10,465 | 425,716 | 186,152 | 196.6 K to 186.2 K (-5.32 %) |
Oct 13 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 30,000 | 158,400 | 196,617 | 166.6 K to 196.6 K (+18.01 %) |
Oct 13 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 40.12 | 22,906 | 918,989 | 166,617 | 189.5 K to 166.6 K (-12.09 %) |
Oct 13 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 5.28 | 22,906 | 120,944 | 189,523 | 166.6 K to 189.5 K (+13.75 %) |
Sep 14 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 31.00 | 3,689 | 114,359 | 165,141 | 168.8 K to 165.1 K (-2.19 %) |
Sep 14 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Sell | S | 31.00 | 3,689 | 114,359 | 165,141 | 168.8 K to 165.1 K (-2.19 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 0.00 | 5,643 | 0 | 0 | |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Payment of Exercise | F | 32.88 | 1,954 | 64,248 | 6,511 | 8.5 K to 6.5 K (-23.08 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 0.00 | 5,643 | 0 | 8,465 | 2.8 K to 8.5 K (+199.96 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | M | 0.00 | 5,643 | 0 | 0 | |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Payment of Exercise | F | 32.88 | 1,954 | 64,248 | 614,562 | 616.5 K to 614.6 K (-0.32 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Buy | M | 0.00 | 5,643 | 0 | 616,516 | 610.9 K to 616.5 K (+0.92 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 5,643 | 0 | 0 | |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Payment of Exercise | F | 32.87 | 1,954 | 64,228 | 1,006,511 | 1 M to 1 M (-0.19 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | M | 0.00 | 5,643 | 0 | 1,008,465 | 1 M to 1 M (+0.56 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | M | 0.00 | 5,643 | 0 | 0 | |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Payment of Exercise | F | 32.88 | 1,954 | 64,248 | 6,511 | 8.5 K to 6.5 K (-23.08 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Buy | M | 0.00 | 5,643 | 0 | 8,465 | 2.8 K to 8.5 K (+199.96 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | M | 0.00 | 5,643 | 0 | 0 | |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Payment of Exercise | F | 32.88 | 1,954 | 64,248 | 614,562 | 616.5 K to 614.6 K (-0.32 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Buy | M | 0.00 | 5,643 | 0 | 616,516 | 610.9 K to 616.5 K (+0.92 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 5,643 | 0 | 0 | |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Payment of Exercise | F | 32.87 | 1,954 | 64,228 | 1,006,511 | 1 M to 1 M (-0.19 %) |
Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | M | 0.00 | 5,643 | 0 | 1,008,465 | 1 M to 1 M (+0.56 %) |
Aug 20 2020 | DNLI | Denali Therapeutic ... | Ho Carole | Chief Medical Offic ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Aug 20 2020 | DNLI | Denali Therapeutic ... | Schuth Alexander O. | COO and Secretary | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 |